What is a common concern when prescribing Haloperidol due to its side effects?

Haloperidol, an antipsychotic medication, is primarily known for its potential to cause extrapyramidal symptoms (EPS). These are drug-induced movement disorders that can include symptoms such as tremors, rigidity, bradykinesia, and tardive dyskinesia. These side effects result from the medication's action on dopamine receptors in the brain, particularly in the nigrostriatal pathway, which is involved in the regulation of movement.

The risk of developing EPS is a well-documented concern among healthcare providers when prescribing Haloperidol, especially at higher doses or with prolonged use. This makes it essential for nurses and healthcare professionals to monitor patients carefully for signs of these symptoms and educate them about the potential side effects.

While weight gain, hypertension, and addiction potential can be concerns with various medications, they are not as directly associated with Haloperidol as extrapyramidal symptoms. Therefore, the focus on EPS is critical in the context of its prescription and the management of patients on this medication.